Answers are grounded in this paper and cite their sources.
Efficacy evaluation shows increased alcohol abstinence following liver fibrosis screening in individuals with alcohol use disorder, highlighting the behavioral impact of targeted testing.
Individuals with alcohol use disorder (AUD) are at risk of liver disease. There is scarce information on the effectiveness of screening for liver fibrosis on alcohol consumption. Thus, we evaluated the efficacy of a screening program for liver fibrosis on alcohol consumption in individuals with AUD.
No takes yet. Share an insight, caveat, or question.
Avitabile et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: